Literature DB >> 23373677

Investigation of astatine(III) hydrolyzed species: experiments and relativistic calculations.

Julie Champion1, Andréa Sabatié-Gogova, Fadel Bassal, Tahra Ayed, Cyrille Alliot, Nicolas Galland, Gilles Montavon.   

Abstract

This work aims to resolve some controversies about astatine(III) hydroxide species present in oxidant aqueous solution. AtO(+) is the dominant species existing under oxidizing and acidic pH conditions. This is consistent with high-performance ion-exchange chromatography data showing the existence of one species holding one positive charge. A change in speciation occurs as the pH changes from 1 to 4, while remaining under oxidizing conditions. Dynamic experiments with ion-exchange resins evidence the existence of a neutral species witnessed by its elution in the void volume. Batch-experiments using a competition method show the exchange of one proton indicating the formation of the AtO(OH) species. The hydrolysis thermodynamic constant, extrapolated to zero ionic strength, was determined to be 10(-1.9). This value is supported by two-component relativistic quantum calculations and therefore allows disclosing unambiguously the structure of the formed species.

Entities:  

Year:  2013        PMID: 23373677     DOI: 10.1021/jp3099413

Source DB:  PubMed          Journal:  J Phys Chem A        ISSN: 1089-5639            Impact factor:   2.781


  3 in total

1.  Radiopharmaceutical chemistry of targeted radiotherapeutics, part 4: Strategies for 211At labeling at high activities and radiation doses of 211At α-particles.

Authors:  Oscar R Pozzi; Michael R Zalutsky
Journal:  Nucl Med Biol       Date:  2016-12-10       Impact factor: 2.408

2.  Simulation of the distribution of astatine-211 solution dispersion in a lab room.

Authors:  Hitoshi Kubo; Kazuhiro Takahashi; Saki Shimoyama; Songji Zhao; Naoyuki Ukon; Hiroshi Ito
Journal:  Nucl Med Commun       Date:  2021-09-01       Impact factor: 1.698

3.  Targeted radionuclide therapy with astatine-211: Oxidative dehalogenation of astatobenzoate conjugates.

Authors:  David Teze; Dumitru-Claudiu Sergentu; Valentina Kalichuk; Jacques Barbet; David Deniaud; Nicolas Galland; Rémi Maurice; Gilles Montavon
Journal:  Sci Rep       Date:  2017-05-31       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.